11 November 2024
Oxford Nanopore Technologies
plc
("Oxford
Nanopore" or the "Company")
Oxford Nanopore
announces changes
to the senior leadership team
Oxford
Nanopore Technologies plc (LSE: ONT), the company delivering a new
generation of nanopore-based molecular sensing technology, today
announces that Rosemary Sinclair Dokos has been appointed as Chief
Product and Marketing Officer and Dr Lakmal Jayasinghe has been
appointed as Chief Scientific Officer, effective immediately.
Rosemary and Lakmal, who will report to Chief Executive Officer Dr
Gordon Sanghera, succeed Clive Brown, Chief Officer of Technology,
Innovation, and Products, who has stepped down to pursue new
projects. Clive will be available to the business on an advisory
basis to support an effective transition.
Rosemary has more than 18 years' experience in innovation,
including product management and commercial functions. She joined
Oxford Nanopore in 2014 and has been
a pivotal force in driving the Company's
product strategy and execution, overseeing the development of
Oxford Nanopore's platform technologies, including the recent
PromethION 2 and GridION Q-Line launches. In her new role, Rosemary
will continue leading the development of products that include new
multiomic, clinical, biopharma and industrial applications, in
addition to platform technology innovations and marketing.
Lakmal
is a highly respected, world-leading nanopore and protein sensing
scientist and scientific leader, with more than 18 years'
experience. He joined Oxford Nanopore in 2007 and
has been responsible for all biological research
and development projects at Oxford Nanopore. Lakmal will continue to lead efforts to integrate new
multiomic capabilities, including genomics, transcriptomics,
proteomics, and metabolomics, into the Company's
platform.
Dr
Gordon Sanghera, Chief Executive Officer of Oxford Nanopore,
commented:
"Rosemary and Lakmal have played an integral role in the
research, development and execution of our technology vision for
many years. They bring extensive skills in innovation and product
development, and the leadership of highly skilled technical teams.
These span the most cutting-edge innovation to the deployment of
mature products destined for regulated markets - critical to
creating stakeholder value. Their knowledge, perspective and vision
will advance our innovation leadership and fuel the continuation of
our growth journey.
"I
would like to thank Clive for his profound contributions to the
development of the technology and the growth of the business over
the past 16 years. He established the
Company's distinct vision of distributed,
accessible sequencing and fostered a culture of cutting-edge innovation and relentless
pursuit of pushing technological boundaries, which has shaped
Oxford Nanopore into the innovative force it is today.
We continue to deliver against this vision and
will carry forward his drive to deploy big ideas and solve big
problems."
Clive Brown,
former Chief Officer of Technology, Innovation, and Products at
Oxford Nanopore, commented:
"It has
been a privilege to work alongside Gordon, Spike and the leadership
team and I am proud of all that we have achieved over the last 16
years. Given our progress, I am now pursuing my next professional
challenge. Rosemary's focus on
transformative product experiences and Lakmal's pioneering work in
multiomics put the Company in a strong position for the next phase
of its development. I would particularly like to thank the user
community, who continue to work so hard to help us improve and
innovate the technology to enable them to perform breakthrough
science. I remain a dedicated shareholder and look forward to
seeing the Company continue to go from strength to
strength."
-ENDS-
For further information, please
contact:
Oxford Nanopore Technologies plc
Investors: ir@nanoporetech.com
Media:
media@nanoporetech.com
Teneo (communications adviser to the
Company)
Tom Murray, Olivia Peters
+44 (0) 20 7353 4200
OxfordNanoporeTechnologies@teneo.com
About Oxford Nanopore Technologies plc:
Oxford
Nanopore Technologies' goal is to bring the widest benefits to
society through enabling the analysis of anything, by anyone,
anywhere. The Group has developed a new generation of
nanopore-based sensing technology that is currently used for
real-time, high-performance, accessible, and scalable analysis of
DNA and RNA. The technology is used in more than 125
countries, to understand the biology of humans, plants, animals,
bacteria, viruses and environments as well as to understand
diseases such as cancer. Oxford Nanopore's technology also
has the potential to provide broad, high impact, rapid insights in
a number of areas including healthcare, food and
agriculture. For more information please visit:
www.nanoporetech.com